TNFα inhibits IGFBP-3 through activation of p38α and casein kinase 2 in human retinal endothelial cells

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Zhang, Qiuhua ^a   Soderland, Dylan ^b   Steinle, Jena J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Cell Systems Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; DORAMAPIMOD; ENZYME INHIBITOR; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 14; SOMATOMEDIN BINDING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RETINA ENDOTHELIUM CELL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RETINA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

APOPTOSIS; CASEIN KINASE II; CELLS, CULTURED; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MITOGEN-ACTIVATED PROTEIN KINASE 14; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; RETINA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905013793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103578     Document Type: Article

References (23)

1. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, et al. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J 18: 1450-1452. (Pubitemid 39561611)
2. Joussen AM, Doehmen S, Le ML, Koizumi K, Radetzky S, et al. (2009) TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis 15: 1418-1428.
3. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, et al. (2001) Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107: 181-189. (Pubitemid 32096834)
4. Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054. (Pubitemid 30180265)
5. Jiang Y, Zhang Q, Soderland C, Steinle JJ (2012) TNFalpha and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis. Cell Signal 24: 1086-1092.
6. Zhang Q, Jiang Y, Miller MJ, Peng B, Liu L, et al. (2013) IGFBP-3 and TNF-alpha Regulate Retinal Endothelial Cell Apoptosis. Invest Ophthalmol Vis Sci 54: 5376-5384.
7. Granata R, Trovato L, Garbarino G, Taliano M, Ponti R, et al. (2004) Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 18: 1456-1458.
8. Conover CA (1992) Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130: 3191-3199.
9. Baxter RC (2001) Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 54: 145-148.
10. Chen X, Ferry RJ, Jr. (2006) Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells. Growth Horm IGF Res 16: 41-48. (Pubitemid 43205313)
11. Zhang Q, Guy K, Pagadala J, Jiang Y, Walker RJ, et al. (2012) Compound 49b Prevents Diabetes-Induced Apoptosis through Increased IGFBP-3 Levels. Invest Ophthalmol Vis Sci 53: 3004-3013.
12. Jiang Y, Zhang Q, Steinle JJ (2014) Intravitreal Injection of IGFBP-3 Restores Normal Insulin Signaling in Diabetic Rat Retina. PLoS One 9: e93788.
13. Zhang Q, Steinle JJ (2013) DNA-PK phosphorylation of IGFBP-3 is required to Prevent Apoptosis in Retinal Endothelial cells cultured in High Glucose. Invest Ophthalmol Vis Sci.
14. Leibowitz BJ, Cohick WS (2009) Endogenous IGFBP-3 is required for both growth factor-stimulated cell proliferation and cytokine-induced apoptosis in mammary epithelial cells. J Cell Physiol 220: 182-188.
15. Sayed M, Kim SO, Salh BS, Issinger OG, Pelech SL (2000) Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase. J Biol Chem 275: 16569-16573. (Pubitemid 30398881)
16. Coverley JA, Martin JL, Baxter RC (2000) The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 141: 564-570. (Pubitemid 32250480)
17. Coverley JA, Baxter RC (1997) Phosphorylation of insulin-like growth factor binding proteins. Mol Cell Endocrinol 128: 1-5. (Pubitemid 27158124)
18. Mirzaa GM, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, et al. (2014) De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. Nat Genet 46: 510-515.
19. Panjala SR, Jiang Y, Kern TS, Thomas SA, Steinle JJ (2011) Increased tumor necrosis factor-alpha, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the beta-adrenergic receptor knockout mouse. Mol Vis 17: 1822-1828.
20. Jiang Y, Zhang Q, Liu L, Tang J, Kern TS, et al. (2013) beta2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype. PLoS One 8: e70555.
21. Jiang Y, Walker RJ, Kern TS, Steinle JJ (2010) Application of isoproterenol inhibits diabetic-like changes in the rat retina. Exp Eye Res 91: 171-179.
22. Markelic M, Velickovic K, Golic I, Otasevic V, Stancic A, et al. (2011) Endothelial cell apoptosis in brown adipose tissue of rats induced by hyperinsulinaemia: the possible role of TNF-alpha. European journal of histochemistry : EJH 55: e34.
23. Zhang Q, Jiang Y, Toutounchian JJ, Soderland C, Yates CR, et al. (2013) Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions. Mol Vis 19: 796-803.